Partial splenic embolization for the treatment of hypersplenism in liver transplanted patients with hepatitis C virus recurrence before peg-interferon plus ribavirin.
Bárcena
Rafael
R
Gil-Grande
Luis
L
Moreno
Javier
J
Foruny
José R
JR
Otón
Elena
E
García
Miguel
M
Blázquez
Javier
J
Sánchez
Juan
J
Moreno
Ana
A
Moreno
Alberto
A
D000998:Antiviral Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004621:Embolization, Therapeutic / Q000379:methods*; D006526:Hepatitis C / Q000188:drug therapy / Q000601:surgery*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000379:methods*; D008297:Male; D008875:Middle Aged; D010976:Platelet Count; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D012008:Recurrence; D012254:Ribavirin / Q000627:therapeutic use*; D013154:Spleen / Q000601:surgery*; D016896:Treatment Outcome
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C417083:peginterferon alfa-2b